Human Milk Oligosaccharides Market Size Is Expected To Reach USD 688.5 Million By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEilDFMR9bP3ODhfrEHVjAgIHXAahAZuB5qEFw9Btvcqs5NbcYMBqnlai8KBztRF5CNpehC7CCs3haxSbJqpkfIrdxbPZXJTsTDU3MZvDIzzmMIssF5fqqhxDQjmPoFkVfusVzo1IO94kmTgthQ8eFWRKhxSFDGv_vz96uCBrJg39zH788vr5TXGTWA-gQ80/s320/Human%20Milk%20Oligosaccharides%20Market.png)
San Francisco, 5 April 2024: The Report Human Milk Oligosaccharides Market Size, Share & Trends Analysis Report By Type (2’FL, 3’FL, 3’SL, 6’SL, LNT, LNnT), By Application (Food & Beverages, Dietary Supplements, Infant Formula, Pharmaceuticals), By Region, And Segment Forecasts, 2024 - 2030 The global human milk oligosaccharides market size is expected to reach USD 688.5 million by 2030, expanding at a CAGR of 14.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The global market for human milk oligosaccharides (HMOs) is being driven by several key factors. Firstly, there is a growing awareness among consumers about the health benefits of HMOs. Human milk is known to contain a complex mixture of bioactive compounds, and HMOs are one of the most abundant components. HMOs play a crucial role in supporting the development of a healthy immune system, promoting the growth of beneficial gut bacteria, and reducing the risk of certain diseases. Secondly,